A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

NCT07477457 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Osteosarcoma
Metastasis

Interventions

DRUG: Methotrexate
DRUG: Doxorubicin
DRUG: Cisplatin
DRUG: Gefitinib
DRUG: Trametinib
DRUG: Disulfiram
DRUG: Sunitinib
DRUG: Ifosfamide
PROCEDURE: Biopsy

Sponsor

Memorial Sloan Kettering Cancer Center